Clinical Trial Update: Evaluation of Mirabegron Versus Tamsulosin or Their Combination in Treatment of Lower Urinary Tract Symptoms [NA]

View source ↗

Summary

A clinical trial comparing mirabegron, tamsulosin, or their combination for lower urinary tract symptoms related to ureteric stent morbidity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Symptoms

Drugs mentioned

• Mirabegron (mirabegron)
• Tamsulosin (tamsulosin)

Snippet

Sponsor: Avraiem Talaat | Conditions: Ureteric Stent-related Morbidity | NA | Status: COMPLETED